These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 7665845)
1. Perspectives in the treatment of liver fibrosis. Mavier P; Mallat A J Hepatol; 1995; 22(2 Suppl):111-5. PubMed ID: 7665845 [No Abstract] [Full Text] [Related]
2. Pathogenesis, experimental manipulation and treatment of liver fibrosis. Arthur MJ Exp Nephrol; 1995; 3(2):90-5. PubMed ID: 7773644 [No Abstract] [Full Text] [Related]
3. [Therapeutical targets for revert liver fibrosis]. García B L; Gálvez G J; Armendáriz B J Rev Med Chil; 2007 Jun; 135(6):783-91. PubMed ID: 17728907 [TBL] [Abstract][Full Text] [Related]
4. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy. Castilla A; Prieto J; Fausto N N Engl J Med; 1991 Apr; 324(14):933-40. PubMed ID: 1900574 [TBL] [Abstract][Full Text] [Related]
5. The antifibrotic effects of TGF-β1 siRNA on hepatic fibrosis in rats. Lang Q; Liu Q; Xu N; Qian KL; Qi JH; Sun YC; Xiao L; Shi XF Biochem Biophys Res Commun; 2011 Jun; 409(3):448-53. PubMed ID: 21600192 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis. Liu X; Hu H; Yin JQ Liver Int; 2006 Feb; 26(1):8-22. PubMed ID: 16420505 [TBL] [Abstract][Full Text] [Related]
7. Type I procollagen production and cell proliferation is mediated by transforming growth factor-beta in a model of hepatic fibrosis. Eghbali-Fatourechi G; Sieck GC; Prakash YS; Maercklein P; Gores GJ; Fitzpatrick LA Endocrinology; 1996 May; 137(5):1894-903. PubMed ID: 8612529 [TBL] [Abstract][Full Text] [Related]
17. Down-regulation of connective tissue growth factor and type I collagen mRNA expression by connective tissue growth factor antisense oligonucleotide during experimental liver fibrosis. Uchio K; Graham M; Dean NM; Rosenbaum J; Desmoulière A Wound Repair Regen; 2004; 12(1):60-6. PubMed ID: 14974966 [TBL] [Abstract][Full Text] [Related]
18. Targeting fibrosis for the treatment of heart failure: a role for transforming growth factor-β. Edgley AJ; Krum H; Kelly DJ Cardiovasc Ther; 2012 Feb; 30(1):e30-40. PubMed ID: 21883991 [TBL] [Abstract][Full Text] [Related]
19. Novel anti-fibrotic modalities for liver fibrosis: molecular targeting and regenerative medicine in fibrosis therapy. Inagaki Y; Higashiyama R; Higashi K J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():85-8. PubMed ID: 22320923 [TBL] [Abstract][Full Text] [Related]
20. Epithelial-mesenchymal interactions in fibrosis and repair. Transforming growth factor-β activation by epithelial cells and fibroblasts. Sheppard D Ann Am Thorac Soc; 2015 Mar; 12 Suppl 1(Suppl 1):S21-3. PubMed ID: 25830829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]